Follistatin N terminus differentially regulates muscle size and fat in vivo

Delivery of follistatin (FST) represents a promising strategy for both muscular dystrophies and diabetes, as FST is a robust antagonist of myostatin and activin, which are critical regulators of skeletal muscle and adipose tissues. FST is a multi-domain protein, and deciphering the function of different domains will facilitate novel designs for FST-based therapy. Our study aims to investigate the role of the N-terminal domain (ND) of FST in regulating muscle and fat mass in vivo. Different FST constructs were created and packaged into the adeno-associated viral vector (AAV). Overexpression of wild-type FST in normal mice greatly increased muscle mass while decreasing fat accumulation, whereas overexpression of an N terminus mutant or N terminus-deleted FST had no effect on muscle mass but moderately decreased fat mass. In contrast, FST-I-I containing the complete N terminus and double domain I without domain II and III had no effect on fat but increased skeletal muscle mass. The effects of different constructs on differentiated C2C12 myotubes were consistent with the in vivo finding. We hypothesized that ND was critical for myostatin blockade, mediating the increase in muscle mass, and was less pivotal for activin binding, which accounts for the decrease in the fat tissue. An in vitro TGF-beta1-responsive reporter assay revealed that FST-I-I and N terminus-mutated or -deleted FST showed differential responses to blockade of activin and myostatin. Our study provided direct in vivo evidence for a role of the ND of FST, shedding light on future potential molecular designs for FST-based gene therapy

Single Tyrosine Mutation in AAV8 and AAV9 Capsids Is Insufficient to Enhance Gene Delivery to Skeletal Muscle and Heart

Site-directed mutations of tyrosine (Y) to phenylalanine (F) on the surface of adeno-associated viral (AAV) capsids have been reported as a simple method to greatly enhance gene transfer in vitro and in vivo. To determine whether the Y-to-F mutation could also enhance AAV8 and AAV9 gene transfer in skeletal muscle and heart to facilitate muscular dystrophy gene therapy, we investigated four capsid mutants of AAV8 (Y447F or Y733F) and AAV9 (Y446F or Y731F). The mutants and their wild-type control AAV8 and AAV9 capsids were used to package reporter genes (luciferase or β-galactosidase) resulting in similar vector yields. To evaluate gene delivery efficiencies, especially in muscle and heart, the vectors were compared side by side in a series of experiments in vivo in two different strains of mice, the outbred ICR and the inbred C57BL/6. Because AAV8 and AAV9 are among the most effective in systemic gene delivery, we first examined the mutant and wild-type vectors in neonatal mice by intraperitoneal injection, or in adult mice by intravenous injection. To our surprise, no statistically significant differences in transgene expression were observed between the mutant and wild-type vectors, regardless of the reporter genes, vector doses, and the ages and strains of mice used. In addition, quantitative analyses of vector DNA copy number in various tissues from mice treated with mutant and wild-type vectors also showed similar results. Finally, direct intramuscular injection of the above-described vectors with the luciferase gene into the hind limb muscles revealed the same levels of gene expression between mutant and wild-type vectors. Our results thus demonstrate that a single mutation of Y447F or Y733F on capsids of AAV8, and of Y446F or Y731F on AAV9, is insufficient to enhance gene delivery to the skeletal muscle and heart

TIPE2 regulates periodontal inflammation by inhibiting NF-κB p65 phosphorylation

The roles and molecular mechanisms of tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) in periodontitis remain largely unknown. Objective: This study aimed to determine the expression of TIPE2 and NF-κB p65 in rat Porphyromonas gingivalis-induced periodontics in vivo. Methodology: Periodontal inflammation and alveolar bone resorption were analyzed using western blotting, micro-computed tomography, TRAP staining, immunohistochemistry, and immunofluorescence. THP-1 monocytes were stimulated using 1 μg/ml Pg. lipopolysaccharide (Pg.LPS) to determine the expression of TIPE2 in vitro. TIPE2 mRNA was suppressed by siRNA transfection, and the transfection efficiency was proven using western blotting and real-time PCR. The NF-κB pathway was activated by treating the cells with 1 μg/ml Pg.LPS to explore related mechanisms. Results: The expression of both TIPE2 and NF-κB p65 was increased in the gingival tissues of rat periodontitis compared with normal tissues. Positive expression of TIPE2 was distributed in inflammatory infiltrating cells and osteoclasts in the marginal lacunae of the alveolar bone. However, strong positive expression of TIPE2 in THP-1 was downregulated after Pg.LPS stimulation. TIPE2 levels negatively correlated with TNF-α and IL-1β. Decreased TIPE2 in THP-1 further promoted NF-κB p65 phosphorylation. Mechanistically, TIPE2 knockdown upregulated NF-κB signaling pathway activity. Conclusions: Taken together, these findings demonstrate that TIPE2 knockdown aggravates periodontal inflammatory infiltration via NF-κB pathway. Interventions aimed at increasing TIPE2 may help in the therapeutic applications for periodontitis

BClean: A Bayesian Data Cleaning System

There is a considerable body of work on data cleaning which employs various principles to rectify erroneous data and transform a dirty dataset into a cleaner one. One of prevalent approaches is probabilistic methods, including Bayesian methods. However, existing probabilistic methods often assume a simplistic distribution (e.g., Gaussian distribution), which is frequently underfitted in practice, or they necessitate experts to provide a complex prior distribution (e.g., via a programming language). This requirement is both labor-intensive and costly, rendering these methods less suitable for real-world applications. In this paper, we propose BClean, a Bayesian Cleaning system that features automatic Bayesian network construction and user interaction. We recast the data cleaning problem as a Bayesian inference that fully exploits the relationships between attributes in the observed dataset and any prior information provided by users. To this end, we present an automatic Bayesian network construction method that extends a structure learning-based functional dependency discovery method with similarity functions to capture the relationships between attributes. Furthermore, our system allows users to modify the generated Bayesian network in order to specify prior information or correct inaccuracies identified by the automatic generation process. We also design an effective scoring model (called the compensative scoring model) necessary for the Bayesian inference. To enhance the efficiency of data cleaning, we propose several approximation strategies for the Bayesian inference, including graph partitioning, domain pruning, and pre-detection. By evaluating on both real-world and synthetic datasets, we demonstrate that BClean is capable of achieving an F-measure of up to 0.9 in data cleaning, outperforming existing Bayesian methods by 2% and other data cleaning methods by 15%.Comment: Our source code is available at https://github.com/yyssl88/BClea

Controlled oxygen doping in highly dispersed Ni-loaded g-C3N4 nanotubes for efficient photocatalytic H2O2 production

Hydrogen peroxide (HO) is both a key component in several industrial processes and a promising liquid fuel. The production of HO by solar photocatalysis is a suitable strategy to convert and store solar energy into chemical energy. Here we report an oxygen-doped tubular g-CN with uniformly dispersed nickel nanoparticles for efficient photocatalytic HO generation. The hollow structure of the tubular g-CN provides a large surface with a high density of reactive sites and efficient visible light absorption during the photocatalytic reaction. The oxygen doping and Ni loading enable a fast separation of photogenerated charge carriers and a high selectivity toward the two-electron process during the oxygen reduction reaction (ORR). The optimized composition, Ni/OtCN, displays an HO production rate of 2464 μmol g·h, which is eightfold higher than that of bulk g-CN under visible light irradiation (λ > 420 nm), and achieves an apparent quantum yield (AQY) of 28.2% at 380 nm and 14.9% at 420 nm.IREC and ICN2 acknowledge funding from Generalitat de Catalunya, projects 2017 SGR 1246 and 2017 SGR 327, respectively. The authors thank the support from the project COMBENERY (PID2019-105490RB-C32) and NANOGEN (PID2020-116093RB-C43), funded by MCIN/ AEI/10.13039/501100011033/. ICN2 is supported by the Severo Ochoa program from Spanish MINECO (Grant No. SEV-2017-0706) and is funded by the CERCAProgramme / Generalitat de Catalunya. Baoying Li and Jianbin Chen greatly appreciate the financial support from the National Natural Science Foundation of China (Nos. 22171154 & 21801144), the Youth Innovative Talents Recruitment and Cultivation Program of Shandong Higher Education, The Project Supported by the Foundation (No. ZZ20190312) of State Key Laboratory of Biobased Material and Green Papermaking, Qilu University of Technology (Shandong Academy of Sciences)

K137R Mutation on Adeno-Associated Viral Capsids Had Minimal Effect on Enhancing Gene Delivery In Vivo

The adeno-associated viral (AAV) vector has emerged as an attractive vector for gene therapy applications. Development of AAV vectors with enhanced gene transduction efficiency is important to ease the burden of AAV production and minimize potential immune responses. Rational mutations on AAV capsids have gained attention as a simple method of enhancing AAV transduction efficiency. A single-amino acid mutation, K137R, on AAV1 and AAV8 was recently reported to increase liver transgene expression by 5–10-fold. To determine whether the same mutation on other AAV serotypes would result in similar gene enhancement effects, K137R mutants were generated on AAV7, AAV8, and AAV9, and their effects were evaluated in vivo. Two reporter genes were utilized: the nuclear LacZ gene driven by the cytomegalovirus promoter and the luciferase gene driven by the CB promoter. Surprisingly, we found no difference in luciferase gene expression in the liver or other tissues using either the wild-type AAV8 capsid or AAV8-K137R. LacZ gene expression in the liver by AAV8-K137R was about onefold higher than that of wild-type AAV8. However, no difference was found in other tissues, such as skeletal muscle and cardiac muscle. In addition, no difference was found in transgene expression with either AAV7-K137R or AAV9-K137R mutants. Our results indicated that the K137R mutation on AAV7, AAV8, and AAV9 had minimal to no effect on transduction efficiency in vivo